Sub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial virus. - Test2 - elhamkhani - TriplyDB

Sub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial virus.

Sub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial virus.

http://www.wikidata.org/entity/Q33323372

about

Vaccines: the Fourth Century Prophylactic administration of bacterially derived immunomodulators improves the outcome of influenza virus infection in a murine model.Characterization of an experimental vaccine for bovine respiratory syncytial virus.Nucleoprotein nanostructures combined with adjuvants adapted to the neonatal immune context: a candidate mucosal RSV vaccine.Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies Nanoparticle vaccines encompassing the respiratory syncytial virus (RSV) G protein CX3C chemokine motif induce robust immunity protecting from challenge and disease.Recent advances in diagnosis, prevention, and treatment of human respiratory syncytial virus.A novel subnucleocapsid nanoplatform for mucosal vaccination against influenza virus that targets the ectodomain of matrix protein 2.Novel therapies and vaccines against the human respiratory syncytial virus.RSV N-nanorings fused to palivizumab-targeted neutralizing epitope as a nanoparticle RSV vaccine.

P2860

Q27490454-CCF257D4-6BB5-4940-9201-61F67C709D4C Q33676552-2FA85195-270E-47A9-B6B9-26F191037A5A Q33899379-72680E8A-99AA-4F42-A72A-404889B4B52A Q34289051-25122733-857A-43EC-A0FF-EAB50DBB6A6D Q34425648-4BC4CA5F-5607-4E5D-A923-A5B92EFEF8BF Q34990420-CCA36E2E-622F-423D-AD82-210F4DB9CD3F Q37412509-C5773BB1-034A-4E7F-BF73-9BBD0B34B986 Q37547653-932CAE65-E609-4EE8-B1FD-5BE19B647630 Q38604787-DDCB6480-4C63-4D04-A810-7FA738DDA9BF Q40565908-E294F3DC-1A6D-4A48-8D35-531763A1E0FC

P2860

Sub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial virus.

http://www.wikidata.org/entity/Q33323372

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

name

Sub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial virus.

@ast

Sub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial virus.

@en

Sub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial virus.

@nl

type

label

Sub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial virus.

@ast

Sub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial virus.

@en

Sub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial virus.

@nl

prefLabel

Sub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial virus.

@ast

Sub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial virus.

@en

Sub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial virus.

@nl

P1433

Q33323372-D6140204-48FB-4C3C-8AA7-889D48EE390D

P1476

Q33323372-96783420-3E1C-4C76-BA13-69B4D61A8053

P2093

Q33323372-0DD3DD85-BA47-464F-BA05-EE43182EA8C2

Q33323372-149B7986-7361-4585-AB37-459393E771E2

Q33323372-1E2C0DB0-24C5-49DA-A53F-634632D75CB5

Q33323372-38444E67-05F7-46A7-8943-FA884809EF61

Q33323372-93437A74-C3EA-41DE-89B6-6FBE8D16D99E

Q33323372-99DEF342-07C0-40F1-802F-B465D19BB7DF

Q33323372-AF0BFA9F-98A3-49BA-861F-6090BD8FADDE

Q33323372-B556C15F-ECD9-41A7-A98F-2FF25BAF7DBA

Q33323372-C60E6D27-F1F0-48D2-9023-96FB37145787

P2860

Q33323372-02733B36-57E5-4E08-8F39-0D4A135EFF37

Q33323372-02F30230-7136-4629-AE14-DD556FF72A26

Q33323372-0C81D478-0193-42AC-80B0-10D005F1C359

Q33323372-0CDCA212-3B39-4F5F-A452-CA46A597ECD1

Q33323372-0D46DBA4-D71D-4FF4-948F-6EC5CBE0F5DD

Q33323372-0DDF4285-D630-4B6F-BE09-F2A8D4609EFA

Q33323372-12AFFC24-EEDB-455A-96EB-F76E964BF6E6

Q33323372-1CD4D793-0B04-4B55-A2CD-2192F7BE14CC

Q33323372-1E784DC8-0E5F-44A7-8499-70DD658A1BE7

Q33323372-21AECD71-1D00-4F5B-AD03-54E781DC7F7A

P304

Q33323372-5140ADA3-A312-4A43-BE59-CE61BBBD0D0D

P31

Q33323372-2FA4ADA0-0106-4110-8986-1C4192A631D6

P356

Q33323372-29C81F16-DB31-4AC9-BEAE-8993298C3E9D

P407

Q33323372-CD7935C4-4348-4210-B910-EE03FD7F50E1

P433

Q33323372-81FC23A7-24DC-4DC4-8DE5-964BEC77D750

P478

Q33323372-6C18009B-4C77-4D44-A4A5-9CB943BBA790

P577

Q33323372-35FAA8AB-CC96-470C-A31A-33F17C554FDA

P5875

Q33323372-ECC3B824-DE42-43BC-835F-73378157C431

P698

Q33323372-AE7C2E16-7420-4CD3-9F87-349D1DD20578

P921

Q33323372-94FF004B-347A-45AB-893B-8BBA7B3DC08E

Q33323372-DD751FD7-0749-4084-B359-067937300027

P932

Q33323372-0E558ADA-3D9E-4EEB-AF3C-793CE692968E

P356

JOURNAL.PONE.0001766

P1433

P1476

Sub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial virus.

@en

P2093

Agnès Petit-Camurdan

http://www.w3.org/2001/XMLSchema#string

Catherine Dubuquoy

http://www.w3.org/2001/XMLSchema#string

Guillaume Durand

http://www.w3.org/2001/XMLSchema#string

Jean-François Eléouët

http://www.w3.org/2001/XMLSchema#string

Julie Bernard

http://www.w3.org/2001/XMLSchema#string

Nathalie Castagné

http://www.w3.org/2001/XMLSchema#string

Sabine Riffault

http://www.w3.org/2001/XMLSchema#string

Thi-Lan Tran-Tolla

http://www.w3.org/2001/XMLSchema#string

Xavier Roux

http://www.w3.org/2001/XMLSchema#string

P2860

Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model.

Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection.

Nucleotide sequence analysis of a matrix and small hydrophobic protein dicistronic mRNA of bovine respiratory syncytial virus demonstrates extensive sequence divergence of the small hydrophobic protein from that of human respiratory syncytial virus.

Protective role of gamma interferon during the recall response to influenza virus.

Characterization of a novel respiratory syncytial virus-specific human cytotoxic T-lymphocyte epitope.

Immune responses and disease enhancement during respiratory syncytial virus infection

A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses.

Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.

Neonatal and early life vaccinology.

Gamma interferon-dependent protection of the mouse upper respiratory tract following parenteral immunization with a respiratory syncytial virus G protein fragment

P304

e1766

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0001766

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5517348

http://www.w3.org/2001/XMLSchema#string

P698

18335041

http://www.w3.org/2001/XMLSchema#string

P921

P932

2262139

http://www.w3.org/2001/XMLSchema#string